Translational Research Development Program

You are here

The Translational Research Development Program (TRDP), formerly known as the F&T Trainee Program, has expanded its eligibility criteria and is available to postdoctoral and predoctoral trainees. The program aims to provide an opportunity for early stage investigators to gain significant experience with clinical and translational research, and provides research funds up to $16,000 available over two years.

Letters of Intent (LOIs) were due July 8. We will invite select applicants to submit full proposals by July 22, with full proposals due by 5pm on August 21. 

Learn more

Program overview
    • Expanded its eligibility criteria and is available to:
      • Predoctoral trainees pursuing a PhD in a PhD graduate program or PhD dual degree program who have passed their written and oral preliminary examinations
      • Postdoctoral trainees, including medical fellows, who are no more than 3 years into their postdoctoral training.
    • Aims to provide an opportunity for early stage investigators to gain significant experience with clinical and translational research.
    • Research funds up to $16,000 available over two years
    • Requires a primary research mentor and a translational mentor, such as a senior faculty member or biostatistician, who will help guide and advise the TRDP project
Application details
Program deadlines
    • July 8, 2014 (5:00pm): LOIs due
    • July 22, 2014: Invite full proposals
    • August 21, 2014 (5:00pm): Full proposals due
    • September 1, 2014: Program start date  
Nature and purpose of this RFA

The Clinical and Translational Science Institute (CTSI) will provide institutional research funds for predoctoral and postdoctoral trainees with a demonstrable and significant interest in clinical or translational research focused on human health. The program aims to provide an opportunity for early stage investigators to gain significant experience with clinical and translational research as a foundation for the development of an independent research career focused on human health.

Funds are designed to support a modest research project that will result in a publication in a peer reviewed journal. The TRDP project is secondary to the applicant’s primary research endeavors and must advance the trainee’s research along the clinical and translational research spectrum (see below). For example, a TRDP project for a trainee currently conducting basic research (T0) should be in the T1, T2, T3, or T4 translational categories. Similarly, a trainee currently conducting health services research (T3) should develop a TRDP project that demonstrates a clear movement toward the T4 category.

Current scholars

Daniel Beisang
Project title: Quantitative Assessment of the Diversity of the Neonatal T cell Repertoire

Caroline Diep
Project title: En vivo modeling of primary ovarian cancer cells in 3D culture systems

Anne Frosch, M.D.
Project title: The effect of HIV infection on malaria specific B cell subset frequency

David Knorr
Project title: Evaluation of the CD4+ T cell response against influenza following hematopoietic cell transplantation

Benjamin Hanisch
Project title: Impact of Iron Supplementation on Oxidative Stress in Children Recovering from Severe Malaria

Jessica Musselman, M.S. 
Project title: Methylation of the BMP/TGFβ pathway and correlation with survival in childhood germ cell tumors

Brent Sorenson
Project title: Tumor-targeted reduction of hyopxia-inducible factor in oral carcinoma by calprotectin

Alexa Weingarden
Project title: Bacterial Bile Acid Metabolism in Fecal Transplantation Treatment of Clostridium difficile Infection

Former scholars

The following scholars have advanced to another CTSI career development program:

Alexa Pragman (current CTSI KL2 scholar)
Project title: Comparison of the Oral and Lung Microbiota in Chronic Obstructive Pulmonary Disease